Intravenous Lipo-PGE1 (Eglandin®) therapy in peripheral vascular diseases secondary to systemic lupus erythematosus and systemic sclerosis

S. H. Lee, Y. M. Park, E. S. Oh, J. K. Min, S. H. Park, C. S. Cho, H. Y. Kim

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Intravenous Lipo-PGE1 (Eglandin®) therapy in peripheral vascular diseases secondary to systemic lupus erythematosus and systemic sclerosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science